LEIGH REESE: Open Payments
NPI 1235907031 · CLAIRTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 42 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $386 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 16 | $245 |
| ABBVIE INC. | 16 | $241 |
| Janssen Biotech, Inc. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Novo Nordisk Inc | 1 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Ardelyx, Inc. | 1 | $15 |
| GENZYME CORPORATION | 1 | $15 |
Products named: REZDIFFRA, RINVOQ, SKYRIZI, TREMFYA, EOHILIA, Wegovy, LINZESS, XIFAXAN.
Industry payments across PA — which companies pay providers there.
